Analyst Price Targets — BRKR
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| February 13, 2026 2:44 pm | Evie Koslosky | Goldman Sachs | $35.00 | $37.19 | TheFly | Bruker price target lowered to $35 from $40 at Goldman Sachs |
| February 13, 2026 2:33 pm | — | UBS | $49.00 | $36.99 | TheFly | Bruker price target raised to $49 from $43 at UBS |
| February 13, 2026 11:09 am | Luke Sergott | Barclays | $50.00 | $37.51 | TheFly | Bruker price target lowered to $50 from $55 at Barclays |
| February 12, 2026 7:24 pm | — | Jefferies | $50.00 | $37.51 | TheFly | Bruker price target lowered to $50 from $55 at Jefferies |
| January 26, 2026 2:35 pm | — | Guggenheim | $58.00 | $49.03 | TheFly | Bruker price target raised to $58 from $53 at Guggenheim |
| January 5, 2026 2:26 pm | Subbu Nambi | Guggenheim | $53.00 | $49.87 | TheFly | Bruker price target raised to $53 from $45 at Guggenheim |
| December 15, 2025 11:27 am | Brandon Couillard | Wells Fargo | $55.00 | $45.13 | TheFly | Bruker price target raised to $55 from $48 at Wells Fargo |
| December 15, 2025 10:54 am | — | Barclays | $55.00 | $45.13 | TheFly | Bruker price target raised to $55 from $45 at Barclays |
| December 10, 2025 1:53 pm | — | Wolfe Research | $60.00 | $47.65 | TheFly | Wolfe upgrades Bruker to Outperform on 2026 growth |
| December 9, 2025 9:29 am | — | Goldman Sachs | $40.00 | $46.00 | TheFly | Bruker initiated with a Sell at Goldman Sachs |
Latest News for BRKR
ORLANDO, Fla.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced the launch of CellScape™ XR, a next-generation spatial proteomics platform designed to advance the development of diagnostic and prognostic assays by delivering unprecedented quantitative performance, robustness, and flexibility. CellScape XR addresses a critical bottleneck in translational research by enabling…
ORLANDO, Fla.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Spatial Biology, a division of Bruker Corporation (Nasdaq: BRKR) announced today that it will expand its collaboration with Noetik Inc., following their prior study of more than 3500 patient samples with the CosMx® Spatial Molecular Imager (SMI). CosMx SMI powers Noetik's pre-training and scaling of bio-foundation models to perform complex genome-wide…
ORLANDO, Fla.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) announced today significant portfolio advancements from Bruker Spatial Biology to be unveiled at the 2026 Advances in Genome Biology and Technology (AGBT) General Meeting. These updates highlight Bruker's category leadership in spatial biology and its commitment to delivering best‑in‑class solutions across DNA, RNA, and protein. The…
ST. LOUIS--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced new advancements to enable Functional Proteomics 2.0 workflows on the timsOmni™ mass spectrometer to enable disease researchers to move beyond canonical protein lists toward biologically or pathologically functional proteoforms and PTM-resolved peptide variants. New releases in Bruker ProteoScape™, OmniScape™, and…
Examine the evolution of Bruker's (BRKR) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.